(VIANEWS) - Colfax Corporation (CFX), Boston Scientific (BSX), Silgan Holdings (SLGN) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Colfax Corporation (CFX)
22.3% sales growth and 3.03% return on equity
Colfax Corporation operates as a diversified technology company worldwide.
Colfax Corporation's sales growth this year is expected to be 25% and 7.9% for next year.
Year-on-year quarterly revenue growth grew by 58.9%, now sitting on 3.5B for the twelve trailing months.
Volume
Today's last reported volume for Colfax Corporation is 1075760 which is 21.43% below its average volume of 1369200.
Colfax Corporation's sales growth is a negative 0% for the present quarter and 22.3% for the next. The company's growth estimates for the present quarter and the next is 34.1% and 23.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.03%.
Volatility
Colfax Corporation's last day, last week, and last month's current volatility was 0.06%, 0.90%, and 1.13%, respectively.
Colfax Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.52% (day), 1.82% (last week), and 1.97% (last month), respectively.
Colfax Corporation's Stock Yearly Top and Bottom Value
Colfax Corporation's stock is valued at $51.59 at 01:22 EST, below its 52-week high of $52.04 and way above its 52-week low of $26.45.
Colfax Corporation's Moving Average
Colfax Corporation's value is above its 50-day moving average of $47.97 and way higher than its 200-day moving average of $46.21.2. Boston Scientific (BSX)
17.5% sales growth and 3.69% return on equity
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
Boston Scientific's sales growth this year is expected to be 21.2% and 7.9% for next year.
Year-on-year quarterly revenue growth grew by 53.6%, now sitting on 11.2B for the twelve trailing months.
Volume
Today's last reported volume for Boston Scientific is 5661110 which is 9.07% below its average volume of 6225930.
Boston Scientific's sales growth is a negative 0% for the current quarter and 17.5% for the next. The company's growth estimates for the current quarter and the next is 8.1% and 91.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.69%.
Volatility
Boston Scientific's last day, last week, and last month's current volatility was 1.35%, 0.70%, and 1.39%, respectively.
Boston Scientific's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.25% (day), 1.97% (last week), and 2.13% (last month), respectively.
Boston Scientific's Stock Yearly Top and Bottom Value
Boston Scientific's stock is valued at $43.24 at 01:22 EST, under its 52-week high of $46.29 and way above its 52-week low of $32.99.
Boston Scientific's Moving Average
Boston Scientific's worth is below its 50-day moving average of $43.88 and below its 200-day moving average of $43.38.Previous days news about Boston Scientific(BSX)
- Nevro announces update in patent litigation with Boston Scientific. According to Business Insider on Monday, 1 November, "Two other Boston Scientific lead patents (8,646,172 and 8,650,747) were not infringed. ", "Nevro Corp.(NYSE: NVRO), a global medical device company that provides innovative, evidence-based solutions for the treatment of chronic pain, today announced that a Delaware jury found that Nevro infringed two Boston Scientific patents (7,891,085 and 8,019,439) directed to ways of manufacturing spinal cord stimulation (SCS) leads, which Nevro obtains from a third-party supplier. "
3. Silgan Holdings (SLGN)
11.8% sales growth and 24.98% return on equity
Silgan Holdings Inc., together with its subsidiaries, manufactures and sells rigid packaging for consumer goods products in North America, Europe, and internationally.
Silgan Holdings's sales growth this year is expected to be 13.2% and 6.9% for next year.
Year-on-year quarterly revenue growth grew by 10.9%, now sitting on 5.46B for the twelve trailing months.
Volume
Today's last reported volume for Silgan Holdings is 194587 which is 44.53% below its average volume of 350843.
Silgan Holdings's sales growth for the next quarter is 11.8%. The company's growth estimates for the current quarter and the next is 21.7% and 12%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 24.98%.
Volatility
Silgan Holdings's last day, last week, and last month's current volatility was 0.75%, 1.26%, and 1.19%, respectively.
Silgan Holdings's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.63% (day), 2.35% (last week), and 2.00% (last month), respectively.
Silgan Holdings's Stock Yearly Top and Bottom Value
Silgan Holdings's stock is valued at $40.19 at 01:22 EST, below its 52-week high of $44.55 and way higher than its 52-week low of $33.62.
Silgan Holdings's Moving Average
Silgan Holdings's value is above its 50-day moving average of $39.72 and under its 200-day moving average of $41.26.4. Gildan Activewear (GIL)
5.1% sales growth and 22.95% return on equity
Gildan Activewear Inc. manufactures and sells a range of apparel products in North America, Europe, the Asia-Pacific, and Latin America.
Gildan Activewear's sales growth this year is anticipated to be 39.5% and 6.4% for next year.
Year-on-year quarterly revenue growth grew by 225.3%, now sitting on 2.63B for the twelve trailing months.
Volume
Today's last reported volume for Gildan Activewear is 435839 which is 18.55% below its average volume of 535150.
Gildan Activewear's sales growth for the next quarter is 5.1%. The company's growth estimates for the present quarter and the next is 83.3% and 17.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 22.95%.
Volatility
Gildan Activewear's last day, last week, and last month's current volatility was 0.16%, 1.28%, and 1.33%, respectively.
Gildan Activewear's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.13% (day), 2.09% (last week), and 2.32% (last month), respectively.
Gildan Activewear's Stock Yearly Top and Bottom Value
Gildan Activewear's stock is valued at $36.72 at 01:22 EST, below its 52-week high of $40.27 and way above its 52-week low of $20.74.